Plenty of run left in Genetic Signatures
May 11, 2020
May 11, 2020 |
There has been continual strong news flow from the Genetic Signature Ltd (ASX: GSS), as it received CE-IVD registration for its SARS-CoV-2 Detection Kit, as well as notification from the Therapeutic Goods Administration (TGA) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to be listed on the ARTG in Australia.
Genetic Signatures builds on SARS technology
Mar 30, 2020
Mar 30, 2020 |
Shares in Genetic Signatures Limited (ASX: GSS) were up 50% at one stage on Monday morning as management announced that the company had supplemented its existing assays to specifically identify the 2019 novel strain of coronavirus (SARS-CoV-2), the virus that causes COVID-19.